HBA1c and Diagnosis of Type 2 Diabetes

Completed

• Conditions: Type 2 Diabetes

• Registration Number: NCT01184768
• Lead Sponsor: University of Tromso

Brief Summary

Following the 6th Tromso study subjects with HbA1c \> 5.7 plus a subsample of subjects with lower hba1c values will be invited to an oral glucose tolerance test to see the predictive value of HBA1c in the diagnosis of type 2 diabetes.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-01
• Study First Submitted: 2010-08-11
• Study First Submitted QC: 2010-08-18
• Study First Posted: 2010-08-19
• Primary Completion: 2010-10
• Study Completion: 2010-11
• Status Verified: 2011-07
• Last Update Submitted: 2011-07-19
• Last Update Posted: 2011-07-20

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 3509

Inclusion Criteria

• participated in the 6 Tromso study

Exclusion Criteria

• type 2 diabetes

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of subjects with new diagnosis of type 2 diabetes	Up to 2 years after participation in the 6th Tromso study

Secondary Outcome Measures

Name	Time	Method
Number of subjects with new diagnosis of impaired glucose tolerance	Up to 2 years after participation in the 6th Tromso study
Effect of vitamin D status on glucose tolerance	Up to 2 years after participation in the 6th Tromso study
Number of subjects with new diagnosis of impaired fasting glucose	Up to 2 years after participation in the 6th Tromso study

Trial Locations

Locations (1)

University Hospital of North Norway; 🇳🇴 Tromsø, Norway